WeVote
Log In

Bill

Bill

A 3620

Relates to the full disclosure of ingredients in certain products

2025 Regular Session Introduced by Nader Sayegh and 1 co-sponsor

Mandates full ingredient disclosure for certain products on packaging and online, boosting consumer visibility of ingredients and allergen information.

REFERRED TO CONSUMER AFFAIRS AND PROTECTION
0
WeVote Research Nonpartisan
Bill Summary · A 3620

Summary of Assembly Bill A 3620

Quick snapshot

  • Bill Number: A 3620
  • Title: Relates to the full disclosure of ingredients in certain products
  • Status: Referred to the Committee on Consumer Affairs and Protection
  • Introduced: January 29, 2025
  • Classification: Bill
  • Related bills (prior-session): A 8544, A 2156, A 7868

Purpose and intent

A 3620, as indicated by its title, seeks to require full disclosure of ingredients in certain products. The exact scope, definitions, and labeling requirements would be detailed in the bill’s text. The basic objective appears to be increasing transparency for consumers by ensuring that all ingredients in covered products are disclosed publicly.

Key provisions (high-level, based on the bill’s title)

  • Ingredient disclosure: The bill would mandate full listing of ingredients for products deemed “certain” under the act. Specific information to be disclosed (e.g., ingredient names, order of predominance, allergens, coatings or additives) would be defined in the text.
  • Disclosure format and access: Provisions could specify how disclosures must appear (e.g., on packaging, labeling, or accompanying materials) and whether disclosures must also be accessible online.
  • Scope and definitions: The bill would define what products are covered and what constitutes “ingredients.” It may also set thresholds or criteria for when disclosure is required.
  • Enforcement and penalties: The act would typically include penalties for noncompliance and designate an appropriate enforcement mechanism or agency oversight (in this case, likely the Consumer Affairs and Protection authority within the state).
  • Effective date and transition: There would be an effective date after enactment and potential phase-in provisions for covered entities to come into compliance.
  • Exemptions and trade secrets: The bill may outline exemptions (e.g., small businesses, certain product categories) and how trade secret protections are balanced with consumer disclosure.

Note: The precise provisions, including definitions, exemptions, and enforcement details, will be in the bill’s official text.

Who would be affected

  • Manufacturers, distributors, and retailers of the covered products that fall under the statute.
  • Consumers, who would gain access to full ingredient information.
  • State regulatory agencies responsible for consumer protection and labeling enforcement.
  • Potentially small businesses or niche product makers, depending on the scope and any exemptions.

Procedural timeline and next steps

  • Introduced January 29, 2025 and immediately referred to the Committee on Consumer Affairs and Protection.
  • No further legislative actions are listed in the provided summary.
  • Next steps typically include committee hearings, potential amendments, and floor votes in the Assembly, followed by consideration in the Senate (if applicable) and the governor’s action.

Related bills

  • A 8544, A 2156, A 7868 (prior-session): These bills are listed as related, suggesting they address similar labeling or ingredient-disclosure themes. They may provide context or precedent for A 3620’s approach.

Considerations for readers

  • The bill’s impact will hinge on the defined scope (which products, what “full disclosure” entails, and any exemptions).
  • Key questions to monitor: how “full disclosure” is defined, whether disclosures must include allergen information, printable labeling requirements, enforcement mechanisms, and any trade-secret protections.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.